Flow cytometry vs. Ki67 labelling index in breast cancer: A prospective evaluation of 181 cases

Anticancer Research

Volumn 22, Issue 1 A, 2002, Pages 295-298

  Martinez Arribas F ^a   Nunez M J ^a   Piqueras, V ^a   Lucas, A R ^a   Sanchez J ^a   Tejerina, A ^a   Schneider, J ^a  

^a Centro de Patologia de la Mama   (Spain)

Author keywords

Breast cancer; Ki67; Ploidy; Proliferation; S phase

Indexed keywords

ANTIBODY; KI 67 ANTIGEN;

ANEUPLOIDY; ANTIBODY LABELING; ARTICLE; BREAST CANCER; CANCER INFILTRATION; CELL CYCLE S PHASE; CELL PROLIFERATION; DIPLOIDY; DNA CONTENT; FEMALE; FLOW CYTOMETRY; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CELL DIVISION; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; PLOIDIES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; S PHASE;

EID: 0036249817     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Method for grading breast cancer
2. S-phase fraction identifies high-risk subgroups among DNA- diploid breast cancers
3. Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity
4. The need for improvement in flow-cytometric analysis of ploidy and S-phase fraction
5. DNA flow cytometric analysis of primary operable breast cancer
6. Proliferation markers
7. Comparative analysis of different approaches to investigate cell kinetics
8. A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction
9. Which proliferation markers for routine histology? A comparison of five antibodies
10. Histologic grade, Ki67 and CD44 are predictors of axillary lymph node invasion in early (T1) breast cancer
11. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast
12. Ki67 index and S-phase fraction in human breast carcinomas. Comparisons and correlation with prognostic factors
13. Proliferative index in breast carcinoma determined in situ by Ki 67 immunostaining and its relationship to clinical and pathological variables
14. Ki67 immunostaining in primary breast cancer: Pathological and clinical associations
15. S-phase fraction and DNA-ploidy in 633 T1T2 breast cancers: A standadized flow cytometric study
16. Chromosomal rearrangements and oncogene amplification precede aneuploidization in the genetic evolution of breast cancer
17. Prognostic significance of DNA ploidy determined by high-resolution flow cytometry in breast carcinoma